Ha Yeon Shin

Ha Yeon Shin

Auto-generated profile, based on publicly available information

Ha Yeon Shin

Department of Biomedical Sciences, Seoul National University Graduate School, Seoul, Korea

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2024 in Journal of Korean Medical Science
Verified
Journal Article
Open access
PDF file
YWYu Ri Woo
Yu Ri Woo
JMJi Hwan Moon
Ji Hwan Moon
HSHa Yeon Shin
Ha Yeon Shin
YBYoon Ji Bang
Yoon Ji Bang
SSSeo Won Song
Seo Won Song
Jung Eun KimJung Eun Kim
Jung Eun Kim
Woo YR, et al. J Korean Med Sci. 2024 Jul;39:e223. https://doi.org/10.3346/jkms.2024.39.e223

24 September 2026 in bioRxiv
Verified
Preprint
Open access
PDF file
JBJulia Young Baik
Julia Young Baik
GPGeon Woo Park
Geon Woo Park
SJSiyeon Jin
Siyeon Jin
JKJiwon Koh
Jiwon Koh
YMYewon Moon
Yewon Moon
HKHyun Je Kim
Hyun Je Kim
Pediatric tonsillar hypertrophy is a leading cause of sleep-disordered breathing in children, yet the immune mechanisms sustaining tonsillar enlargement remain unclear. Using integrated single-cell and spatial profiling of pediatric tonsils in a discovery cohort (n = 45) and independent validation cohort (n = 32), we identify a selective expansion and follicular retention of FCRL4⁺ memory B cells within the mantle zone of hypertrophic tonsils. These cells exhibit a quiescent, tissue-adapted phenotype characterized by NFATC1 repression and reciprocal RUNX1–RUNX2 regulation. Their accumulation is orchestrated by follicular type 1 regulatory T (Tr1) cells, which engage CTLA-4–CD86 checkpoint interactions to suppress plasma cell differentiation and reinforce a local immune tolerance program. Together, these interactions establish a persistent follicular niche enriched in regulatory FCRL4⁺ memory B cells. Our findings delineate a mechanistic Tr1–FCRL4⁺ B cell axis underlying follicular hypertrophy and highlight potential immunomodulatory targets for nonsurgical management of pediatric sleep-disordered breathing.